| 摘要 |
<p>Modified nonpeptide antagonists of endothelin of formula (I), wherein Rc is S(O)p-phenyl, which are useful in treating elevated levels of endothelin, essential renovascular malignant and pulmonary hypertension, cerebral infarction, cerebral ischemia, congestive heart failure and subarachnoid hemorrhage.</p> |
